- Current and Emerging Biologics for Ulcerative Colitis
-
Park SC, Jeen YT
- KMID: 2380778
- Gut Liver.
- 2015 Jan;9(1):18-27.
- doi: 10.5009/gnl14226
Conventional medical treatment for ulcerative colitis can have limited efficacy or severe adverse reactions requiring additional treatment or colectomy. Hence, different biological agents that target specific immunological pathways are being... -
- CITED
-
- Close
- SHARE
-
- Close
- Current concepts in the management of rheumatoid arthritis
-
Tanaka Y
- KMID: 2373796
- Korean J Intern Med.
- 2016 Mar;31(2):210-218.
- doi: 10.3904/kjim.2015.137
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction that causes significant morbidity and mortality. However, the combined use of methotrexate, a synthetic disease-modifying antirheumatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials
-
Song GG, Bae SC, Lee YH
- KMID: 1794631
- Korean J Intern Med.
- 2014 Sep;29(5):656-663.
- doi: 10.3904/kjim.2014.29.5.656
BACKGROUND/AIMS: The aim of this study was to assess the efficacy and safety of tofacitinib (5 and 10 mg twice daily) in patients with active rheumatoid arthritis (RA). METHODS: A systematic... -
- CITED
-
- Close
- SHARE
-
- Close
